Altimmune presents highlights of intranasal covid-19 vaccine and therapeutic programs – adcovid™ and t-covid™ – at the world vaccine congress

Gaithersburg, md., sept. 28, 2020 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that scot roberts, ph.d., chief scientific officer of altimmune, inc., presented an overview of the company’s adcovid and t-covid intranasal vaccine and therapeutic candidates during a special covid-19 virtual session of the world vaccine congress washington, taking place september 28 – october 1, 2020.
ALT Ratings Summary
ALT Quant Ranking